BASEL, Switzerland, Dec. 20, 2016 /PRNewswire/ -- Roche Holdings, Inc. (the “Offeror”) announced today the final results of its previously announced tender offer (the “Offer”) to purchase for cash for an aggregate purchase price (exclusive of accrued and unpaid interest) of up to $250,000,000 (the “Maximum Tender Amount”) the 7.00% Notes due 2039 issued by the Offeror and guaranteed by Roche Holding Ltd (the “Company”) (CUSIP Nos. 771196 AU6 and U75000 AN6) (the “Securities”).
As previously announced, the Offeror accepted for purchase $79,059,000 aggregate principal amount of the Securities that were validly tendered and not validly withdrawn on or prior to 5:00 p.m., New York City time, on December 5, 2016 (the “Early Tender Date”). Settlement in respect of these Securities occurred on December 6, 2016.
Following the Early Tender Date and on or prior to 11:59 p.m., New York City time, on December 19, 2016 (the “Expiration Date”), an additional $1,090,000 aggregate principal amount of the Securities were validly tendered and accepted for purchase. Payment for the Securities that were validly tendered after the Early Tender Date but on or prior to the Expiration Date and accepted for purchase is expected to be made today, December 20, 2016.
The aggregate amount of Securities validly tendered on or prior to the Expiration Date, including the Securities validly tendered and not validly withdrawn on or prior to the Early Tender Date, is set out below:
Title of Security | CUSIP and ISIN | Principal Amount | Principal | Early Tender | Total Consideration |
7.00% Notes | 771196 AU6 | $1,268,987,000 | $80,149,000 | $50.00 | $1,458.04 |
(1) | As of the commencement of the Offer. |
(2) | The Total Consideration includes the Early Tender Premium of $50.00 per $1,000 and is payable in respect of all Securities tendered and accepted for purchase in the Offer. |
The Offer was made upon and was subject to the terms and conditions set forth in the Offer to Purchase dated November 21, 2016, as amended by the Offeror’s press release dated December 6, 2016 announcing that holders of Securities tendered following the Early Tender Date, but on or prior to the Expiration Date, and accepted for purchase will be eligible to receive the Total Consideration (instead of the Tender Offer Consideration).
J.P. Morgan Securities LLC acted as dealer manager for the Offer. The information agent and tender agent for the Offer was D.F. King & Co., Inc. Questions regarding the Offer should be directed to J.P. Morgan Securities LLC, Liability Management Group, at (866) 834-4666 (toll-free), (212) 834-3424 (collect) or London +44 (207) 779-2468.
About the Roche Group
The Company is the parent company of the Offeror. The Company and its consolidated subsidiaries, including the Offeror, are referred to hereinafter as the “Roche Group”.
Founded in 1896 in Basel, Switzerland, the Company is the parent company of an international research-focused healthcare group which is active in over 100 countries and employs more than 91,700 people worldwide. The Roche Group’s products and services address the prevention, diagnosis, treatment and monitoring of diseases.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/roche-holdings-inc-announces-final-results-of-its-debt-tender-offer-300381948.html
SOURCE Roche Holdings, Inc.
